Point72 Asset Management’s Eidos Therapeutics, Inc. Common Stock EIDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q4
Sell
-36,991
Closed -$1.87M 1167
2020
Q3
$1.87M Buy
+36,991
New +$1.87M 0.01% 661
2020
Q1
Sell
-181,200
Closed -$10.4M 1157
2019
Q4
$10.4M Buy
181,200
+14,700
+9% +$844K 0.05% 349
2019
Q3
$5.99M Buy
+166,500
New +$5.99M 0.04% 401
2019
Q1
Sell
-52,000
Closed -$716K 1192
2018
Q4
$716K Buy
52,000
+29,624
+132% +$408K ﹤0.01% 745
2018
Q3
$223K Sell
22,376
-179,404
-89% -$1.79M ﹤0.01% 794
2018
Q2
$4.1M Buy
+201,780
New +$4.1M 0.02% 519